CARLSBAD, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its third quarter 2023 financial results on Monday, November 13, 2023. In conjunction with the […]
Financial
Silk Road Medical Names Chas McKhann Chief Executive Officer
Accomplished Leader with Over 25 Years of Medical Device Industry Experience SUNNYVALE, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road” or the “Company”), a company focused on reducing the risk of stroke and its devastating impact, today announced that Chas McKhann has been appointed […]
Teleflex Announces Quarterly Dividend
WAYNE, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 15, 2023, to shareholders of record at the close of business on […]
Teleflex Reports Third Quarter Financial Results and Full Year 2023 Outlook
WAYNE, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended October 1, 2023. Third quarter financial summary Revenues of $746.4 million, up 8.7% compared to the prior year period; up 7.4% on a constant currency basis GAAP diluted EPS […]
Inari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlow
IRVINE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it has entered into a definitive agreement to acquire LimFlow, S.A., a […]
Covera Health Announces Up to $50M in Additional Series C Funding to Redefine the Role of Radiology Nationwide
Company Expands Industry’s Most Sophisticated AI-Enabled Radiology Performance Platform with Acquisition of CoRead NEW YORK, Nov. 1, 2023 /PRNewswire/ — Covera Health, the leading AI-enabled diagnostic technology company focused on radiology performance measurement and impact, today…
Surmodics Announces Launch of Preside™ Medical Device Coating Technology, Providing Industry-Leading Lubricity and Durability to a Broader Range of Complex Device Applications
EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (NASDAQ: SRDX), the global leader in medical device coating technologies, announced the commercial launch of its most advanced hydrophilic medical device coating technology, Preside™ hydrophilic coatings. Preside hydrophilic coatings complement Surmodics’ existing Serene hydrophilic coatings by providing customers with a unique low-friction and low-particulate generation coating to further enhance distal access for neurovascular applications
SS Innovations Appoints Dr. Sonia Shokeen as Head of Quality and Regulatory Affairs
Dr. Shokeen brings over 15 years of medical device experience, including time spent at Johnson & Johnson FORT LAUDERDALE, FL, Oct. 30, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making […]
Merit Medical Reports Results for Third Quarter Ended September 30, 2023
Q3 2023 reported revenue of $315.2 million, up 9.8% year-over-year Q3 2023 constant currency revenue* up 9.7% year over year Q3 2023 constant currency revenue, organic* up 7.1% year-over-year Q3 2023 GAAP operating margin of 11.1%, compared to 6.5% in Q3 2022 Q3 2023 non-GAAP operating margin* of 18.3%, compared […]
Pulse Biosciences Appoints Dr. Niv Ad as Chief Science Officer, Cardiac Surgery
HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE, “the Company”), a company primarily focused on leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, today announced the appointment of Niv Ad, M.D. as Chief Science Officer, Cardiac Surgery. “After working with the Pulse Biosciences’ team and participating in preclinical studies using the nsPFA clamp for cardiac ablation, it was immediately clear



